SESSION 1: The Promise of Synthetic and Systems Biology for the Understanding and Management of Infectious Diseases
Jesse Goodman, Moderator

10:15–10:45 am

Synthetic biology, systems biology, and microbial threats

James J. Collins, Ph.D., Boston University

10:45–11:15 am

A metabolic engineering platform for discovery and production of new therapeutics

Greg Stephanopoulos, Ph.D., Massachusetts Institute of Technology (MIT)

11:15–11:45 am

Insights into pathogen-host interactions from systems biology

Bernhard Palsson, Ph.D., University of California, San Diego

11:45–12:15 pm

Commercial applications of synthetic biology

David Berry, M.D., Ph.D., Flagship Ventures

12:15–12:45 pm


12:45–1:30 pm


SESSION 2: “The Basics” of Synthetic Biology: Bottom-Up vs. Top-Down Approaches
George Poste, Moderator

1:30–2:00 pm

Systems for synthetic biology

Hans Westerhoff, Ph.D., University of Manchester and the VU University Amsterdam

2:00–2:30 pm

Design and complexity

Herbert Sauro, Ph.D., University of Washington

2:30–3:00 pm

DNA synthesis

George Church, Ph.D., Harvard University

3:00–3:30 pm

Synthetic biology “from scratch”

Gerald Joyce, M.D., Ph.D., The Scripps Research Institute

3:30–3:45 pm


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement